During the past decade, Clinical Trials of South Carolina conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 53 clinical trials were completed, i.e. on average, 86.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 40 clinical trials were completed. i.e. 363.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Trials of South Carolina" #1 sponsor was "Allergan" with 8 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored, "Indivior Inc." with 4 trials sponsored and "Shire" with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Trials of South Carolina" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Trials of South Carolina" are "Bipolar I Disorder" (4 trials), "Gastroparesis" (4 trials), "Schizophrenia" (4 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials) and "Chronic Pain" (3 trials). Many other conditions were trialed in "Clinical Trials of South Carolina" in a lesser frequency.

Most popular intervention types in "Clinical Trials of South Carolina" are "Drug" (72 trials), "Other" (6 trials), "Device" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Galcanezumab" (4 trials), "placebo" (4 trials), "RBP-6000" (3 trials) and "Rapastinel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trials of South Carolina" are 75 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Trials of South Carolina". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Clinical Trials of South Carolina, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trials of South Carolina, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".